PlainPharmaWatch

CMS Open Payments · Program Year 2024

C. R. Bard, Inc. & Subsidiaries

C. R. Bard, Inc. & Subsidiaries reported $1,338,614.69 across General Payments, Research, and Ownership to 2,216 physicians and teaching hospitals across 2,229 transactions.

See the rankings → How this is sourced
$1.3M Above-median payer
All-tracks total
2,229 Top quartile volume
Transactions
2,216 Top quartile reach
Recipients
+$346.7K
General Payments vs PY2023

C. R. Bard, Inc. & Subsidiaries reported $1,338,614.69 across all CMS Open Payments tracks (General + Research + Ownership) to 2,216 physicians and teaching hospitals in Program Year 2024 - ranking #552 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $865,577.30, averaging $604.07 per recipient.

How C. R. Bard, Inc. & Subsidiaries's $1.3M all-tracks total breaks down

C. R. Bard, Inc. & Subsidiaries's payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

41/100

Total payments

F

22/100

Transaction volume

F

26/100

Physician reach

F

27/100

Payment type diversity

A

90/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer c-r-bard-inc-subsidiaries C. R. Bard, Inc. & Subsidiaries

$1.3M · #552/1,925 · 0.0% industry · PY2024

  • TOT $1.3M
  • RANK #552
  • SHARE 0.0%
  • TXN 2,229
  • RCP 2,216
  • CAT 7
  • GEN $865.6K
  • ΔGEN +$346.7K
  • TOP1 27.0%
  • PY 2024

Volume peers

Nearest volume peer: Surmodics, Inc. ($1.3M)

Vericel Corporation$1.3MTelix Pharmaceuticals$1.3MLeadiant Biosciences, Inc.$1.3MSurmodics, Inc.$1.3MC. R. Bard, Inc. & Subsidiar…$1.3M
All-tracks payment totals near C. R. Bard, Inc. & Subsidiaries (CMS Open Payments PY2024)

C. R. Bard, Inc. & Subsidiaries sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

C. R. Bard, Inc. & Subsidiaries's CMS-reported General Payments increased by $346.7K (+66.8%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: C. R. BARD, INC. & SUBSIDIARIESPY2023: C. R. BARD, INC. & SUBSIDIARIESPY2024: C. R. Bard, Inc. & Subsidiaries. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$518.9KPY2024$865.6K
PY2023
$518,889.08
PY2024
$865,577.30

What the Data Shows for C. R. Bard, Inc. & Subsidiaries

Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For C. R. Bard, Inc. & Subsidiaries, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.

10 transactions worth $734.1K make "Debt Forgiveness" the top general-payment category in the 7-category breakdown below, 84.8% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 7 types of general payments, C. R. Bard, Inc. & Subsidiaries's largest category was "Debt Forgiveness" at $734.1K - 84.8% of General Payments.

C. R. Bard, Inc. & Subsidiaries reports 7 general-payment categories - the top three are Debt Forgiveness (84.8%), Food and Beverage (7.5%), and Consulting Fee (4.1%). The remaining 4 categories make up 3.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How C. R. Bard, Inc. & Subsidiaries divides its payments

Top payment categories by total reported dollar volume

1. Debt Forgiveness$734.1K2. Food and Beverage$65.1K3. Consulting Fee$35.6K4. Honoraria$16.6K5. Compensation for Services…$11.9K6. Travel and Lodging$1.2K7. Education$1.0K
Payment Type Amount Transactions
Debt Forgiveness $734.1K 10
Food and Beverage $65.1K 1,967
Consulting Fee $35.6K 12
Honoraria $16.6K 104
Compensation for Services Other Than Consulting $11.9K 116
Travel and Lodging $1.2K 5
Education $1.0K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $745,060.91 (86.1%) of $865,577.30 in this company's General Payments records across 1,317 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for C. R. Bard, Inc. & Subsidiaries

The five named recipients with the highest reported General Payments from this company

Christ Hospital$233.5KWest Suburban Hosp Med Ctr$202.7KSouthwest General Hospital$169.5KBayonne Medical Center$117.6KSriharan Sivalingam$21.8K
  1. 1

    Christ Hospital

    $233,518.27 across 1 reported transactions

  2. 2

    West Suburban Hosp Med Ctr

    $202,717.39 across 2 reported transactions

  3. 3

    Southwest General Hospital

    $169,458.30 across 1 reported transactions

  4. 4

    Bayonne Medical Center

    $117,554.33 across 1 reported transactions

  5. 5

    Sriharan Sivalingam

    $21,812.62 across 13 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

C. R. Bard, Inc. & Subsidiaries's spend rank (#552 of 1,925, top 29% by spend) and concentration rank (#777 of 1,838, top 42% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.

00.30.50.81.11830.51844.01857.51871.01884.5Total payments ($M)Concentration (HHI, 0-10,000)
C. R. Bard, Inc. & Subsidiaries (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as C. R. Bard, Inc. & Subsidiaries's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about C. R. Bard, Inc. & Subsidiaries.

Orchard Therapeutics North America

HHI 1853

HydroCision, Inc.

HHI 1854

Amarin Pharma Inc.

HHI 1855

Zest Holdings, LLC

HHI 1849

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with C. R. Bard, Inc. & Subsidiaries.

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

C. R. Bard, Inc. & Subsidiaries ranks #552 of 1,925 by all-tracks total payments, led by "Debt Forgiveness".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download C. R. Bard, Inc. & Subsidiaries's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.